MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0026446
Sgpharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹21.85 Cr
▲ 70% YoY
Net profit · FY 2025
₹9.22 Cr
Net margin 42.2%
EBITDA · FY 2025
₹12.84 Cr
EBITDA margin 58.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Satisfied charges
₹21.97 Lakh
No open charges
Company age
22 yrs
Est. 2004
Employees · EPFO
26
Provident fund records
About Sgpharma Private Limited
Data last updated:
Sgpharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC146356. Its GSTIN is 27AAICS1181R1ZP (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Chetan Kiritkumar Bhagat and Bhavesh Kiritkumar Bhagat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 542 3/10 Bhuta Niwas Dr Ambedkar Road Matunga (E), Mumbai, Maharashtra, India – 400019.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.85 Cr, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹9.22 Cr (net margin 42.2%) and EBITDA of ₹12.84 Cr (EBITDA margin 58.8%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 12% over five years.
The company has about 26 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: SGPharma. As per MCA filings, the company has satisfied charges of ₹21.97 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Sgpharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0026446). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sgpharma.com.
Company details
CIN U24230MH2004PTC146356
Registration Number 146356
Incorporation Date 17 May 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0026446
Recognitions & Rankings of Sgpharma
Contact details
Sgpharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is sgpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address542 3/10 Bhuta Niwas Dr Ambedkar Road Matunga (E), Mumbai, Maharashtra, India – 400019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sgpharma Private Limited, buy the company report.
Comprehensive company report
Sgpharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sgpharma operates one associated brand: SGPharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and related services. | sgpharma.com |
Business activity
The main business activity of Sgpharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sgpharma Private Limited, buy the company report.
Financials of Sgpharma Private Limited
FY 2025 filings availableSgpharma Private Limited reported revenue of ₹21.85 Cr (up 70% YoY) for FY 2025.
Revenue · FY 2025
₹21.85 Cr ▲ 70%
Net profit · FY 2025
₹9.22 Cr margin 42.2%
EBITDA · FY 2025
₹12.84 Cr margin 58.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 15%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 161%
3 years · compounded
▲ 31%
5 years · compounded
▲ 127%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 70% growth in the latest year. EBITDA rose 161% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.84 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 58.8% | ||||
| Net Profit Margin | 42.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sgpharma Private Limited, buy the company report.
Board of directors of Sgpharma Private Limited
Sgpharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetan Kiritkumar Bhagat Also directs: Sgpharma Global Private Limited | Director | 17 May 2004 | 22 Years 5 Months | Current |
| Bhavesh Kiritkumar Bhagat Also directs: Sgpharma Global Private Limited | Director | 17 May 2004 | 22 Years 5 Months | Current |
Peer comparison
Sgpharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orgamine Chemicals (India) Pvt Ltd | ₹21.91 Cr (FY 2025) | -6.0% | Dombivli East, Maharashtra, India | |||
| Sgpharma Private Limitedthis company | ₹21.85 Cr (FY 2025) | ₹9.22 Cr | 42.2% | 70.0% | 26 | Mumbai, Maharashtra, India |
| Anabiosis Medsciences Private Limited | ₹21.84 Cr (FY 2025) | -1.0% | Sampa, Gujarat, India | |||
| Jayanth Life Sciences Private Limited | ₹21.83 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Trikona Pharmaceuticals Private Limited | ₹21.77 Cr (FY 2025) | 14.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sgpharma Private Limited, buy the company report.
Auditor
Sgpharma Private Limited is audited by CAGK AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CAGK AND CO | FY 2023 | 152566W |
Shareholding
The shareholding of Sgpharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sgpharma Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹21.97 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Nov 2016 | 100189934 | Others | ₹9.97 Lakh | Satisfied | |
| 28 Jun 2016 | 100183911 | Others | ₹12 Lakh | Satisfied |
To see the full charge records of Sgpharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Sgpharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Unimarck Healthcare Ltd Through Ar | Disposed |
To see the full case history of Sgpharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sgpharma Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 211 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 18)
To see the full MSME payment records of Sgpharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Sgpharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Sgpharma Global Private Limited | U24290MH2020PTC350222 |
To see the full group structure of Sgpharma Private Limited, buy the company report.
Employees & EPFO
Sgpharma Private Limited has a workforce of 26 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
26
Active EPFO establishments
1
Employee growth
18.18%
GST
Sgpharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICS1181R1ZP | Maharashtra | Active | 01 Jul 2017 |
| 27AAICS1181R2ZO | Maharashtra | Active | 21 Nov 2019 |
To see the full GST registrations and return filing status of Sgpharma Private Limited, buy the company report.
Recent activity
Sgpharma Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Nayna Mukul Parekh ceased to be Director on 20 Jun 2009.
AGM
Sgpharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sgpharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 14 Nov 2016 via Charge ID 100189934 with Others was fully satisfied on 28 Dec 2021.
Charges
A charge registered on 28 Jun 2016 via Charge ID 100183911 with Others was fully satisfied on 17 Jun 2021.
Charges
A charge with Others amounted to Rs. 9.97 Lakh with Charge ID 100189934 was registered on 14 Nov 2016.
Charges
A charge with Others amounted to Rs. 12.00 Lakh with Charge ID 100183911 was registered on 28 Jun 2016.
Ceased
Nayna Mukul Parekh ceased to be Director.
Appointed
Nayna Mukul Parekh was appointed as Director.
Appointed
Bhavesh Kiritkumar Bhagat was appointed as Director.
Appointed
Chetan Kiritkumar Bhagat was appointed as Director.
Incorporation
17 May 2004
Sgpharma Private Limited was registered on 17 May 2004 with Roc Mumbai I & aged 22 years 5 months as per MCA records.
Frequently asked questions
Sgpharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 2004 (22+ years old) and is registered under CIN U24230MH2004PTC146356.
Sgpharma has 2 current directors:
- Chetan Kiritkumar Bhagat - Director
- Bhavesh Kiritkumar Bhagat - Director
The latest financial statements of Sgpharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sgpharma is 27AAICS1181R1ZP, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAICS1181R2ZO (Maharashtra).
The CIN (Corporate Identification Number) of Sgpharma is U24230MH2004PTC146356. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sgpharma has 1 court case on record: 1 filed against it.
Sgpharma was incorporated on 17 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sgpharma by revenue are Orgamine Chemicals (India) Pvt Ltd, Anabiosis Medsciences Private Limited, Jayanth Life Sciences Private Limited, Trikona Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nayna Mukul Parekh ceased to be Director on 20 Jun 2009. Nayna Mukul Parekh was appointed as Director on 13 Jun 2004. Bhavesh Kiritkumar Bhagat was appointed as Director on 17 May 2004. Sgpharma has 4 board changes on record in total.
Yes, Sgpharma is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0026446).
Sgpharma has 12 MSME Form 1 returns on record between 2019 and 2023, listing 211 overdue payments to 18 micro and small suppliers. The latest return was filed on 19 Dec 2023.
Sgpharma can be reached through the website sgpharma.com. Its registered office is in Mumbai, Maharashtra, India.